Reverse Transcription Polymerase Chain Reaction (RT-PCR) analysis of proteolytic enzymes in cultures of human respiratory epithelial cells

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 24, Issue 2, 2011, Pages 89-101

  Baginski, Leonie ^a,b   Tachon, Gaëlle ^a,c   Falson, Françoise ^c   Patton, John S ^d   Bakowsky, Udo ^b   Ehrhardt, Carsten ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Clinical and Therapeutic Aspects of the Skin Barrier Function   (France)

^d Dance Pharmaceuticals   (United States)

Author keywords

16HBE14o ; A549; Caco 2; Calu 3; human lung epithelial cells; mRNA expression; peptidases; proteases; proteolytic enzymes; pulmonary peptide and protein delivery

Indexed keywords

AMINOPEPTIDASE; AMINOPEPTIDASE B; AMINOPEPTIDASE P1; AMINOPEPTIDASE P2; AMINOPEPTIDASE P3; ANGIOTENSIN CONVERTING ENZYME 2; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE A1; CARBOXYPEPTIDASE A2; CARBOXYPEPTIDASE B; CARBOXYPEPTIDASE M; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL PEPTIDASE IV; ENTEROPEPTIDASE; GAMMA GLUTAMYL HYDROLASE; GAMMA GLUTAMYLTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE 1; GAMMA GLUTAMYLTRANSFERASE 2; GLUTAMYL AMINOPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; MEPRIN; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE; NEUTROPHILIC ELASTASE; PEPTIDASE; PROTEINASE; THIMET OLIGOPEPTIDASE; TRYPSIN; TRYPSIN 1; TRYPSIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; CELL TYPE; ENZYME ANALYSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CACO-2 CELLS; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTESTINAL MUCOSA; PEPTIDE HYDROLASES; RESPIRATORY MUCOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79953902092     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2010.0842     Document Type: Article

References (66)

1. Patton JS, and Byron PR: Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6:67-74. (Pubitemid 46020287)
2. Patton JS: Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev. 1996;19:3-36. (Pubitemid 26167852)
3. Siekmeier R, and Scheuch G: Systemic treatment by inhala-tion of macromolecules\principles, problems, and exam-ples. J Physiol Pharmacol. 2008;59:53-79.
4. Dershwitz M, Walsh JL, Morishige RJ, Connors PM, Rubsamen RM, Shafer SL, and Rosow CE: Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers. Anesthesiology. 2000;3:619-628.
5. Patton JS, Brain JD, Davies LA, Fiegel J, Gumbleton M, Kim KJ, Sakagami M, Vanbever R, and Ehrhardt C: The particle has landed\discerning the fate of inhaled pharmaceuticals. J Aerosol Med Pulm Drug Deliv. (in press).
6. Bernkop-Schnürch A: The use of inhibitory agents to over-come the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release. 1998; 52:1-16. (Pubitemid 28123168)
7. Koshikawa N, Hasegawa S, Nagashima Y, Mitsuhashi K, Tsubota Y, Miyata S, Miyagi Y, Yasumitsu H, and Miyazaki K: Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol. 1998;153:937-944. (Pubitemid 28419046)
8. Jin E, Fujiwara M, Pan X, Ghazizadeh M, Arai S, Ohaki Y, Kajiwara K, Takemura T, and Kawanami O: Protease-Activated Receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas. Cancer. 2003;97:703-713. (Pubitemid 36125848)
9. Cederqvist K, Haglund C, Heikkila P, Hollenberg MD, Karikoski R, and Andersson S: High expression of pul-monary proteinase-activated receptor 2 in acute and chronic lung injury in preterm infants. Pediatr Res. 2005;57: 831-836. (Pubitemid 40727114)
10. Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P, Blalock JE, and Clancy JP: Matrix metallopro-tease-9-dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol. 2007;293:L96-L104. (Pubitemid 47080717)
11. Nagae A, Abe M, Becker RP, Deddish PA, Skidgel RA, and Erdös EG: High concentrations of carboxypeptidase M in lungs: presence of the enzyme in alveolar type I cells. Am J Respir Cell Mol Biol. 1993;9:221-229.
12. Forbes B, Wilson CG, and Gumbleton M: Temporal depen-dence of ectopeptidase expression in alveolar epithelial cell culture: implications for study of peptide absorption. Int J Pharm. 1999; 180: 225-234. (Pubitemid 29238206)
13. Howell S, Kenny AJ, and Turner AJ: A survey of membrane peptidases in two human colonic cell lines, Caco-2 and HT-29. Biochem J. 1992;284(Pt 2):595-601.
14. Yin D, Galivan J, Ao W, and Yao R Characterization of the human gamma-glutamyl hydrolase promoter and its gene expression in human tissues and cancer cell lines. Gene. 2003;312:281-288. (Pubitemid 37338133)
15. Li L, Wang J, and Cooper MD: cDNA cloning and expression of human glutamyl aminopeptidase (aminopeptidase A). Genomics. 1993;17:657-664. (Pubitemid 23282821)
16. Piesse C, Tymms M, Garrafa E, Gouzy C, Lacasa M, Cadel S, Cohen P, and Foulon T: Human aminopeptidase B (rnpep) on chromosome 1q32.2: complementary DNA, genomic structure and expression. Gene. 2002;292:129-140. (Pubitemid 34761996)
17. Dixon J, Kaklamanis L, Turley H, Hickson ID, Leek RD, Harris AL, and Gatter KC: Expression of aminopeptidase-n (CD-13) in normal tissues and malignant neoplasms of epi-thelial and lymphoid origin. J Clin Pathol. 1994;47:43-47 (Pubitemid 24057748)
18. Van der Velden VH, Naber BA, Van Hal PT, Overbeek SE, Hoogsteden HC, and Versnel MA: Peptidase activities in se-rum and bronchoalveolar lavage fluid from allergic asth-matics\comparison with healthy non-smokers and effects of inhaled glucocorticoids. Clin Exp Allergy. 1999;29:813-823. (Pubitemid 29268472)
19. Van der Velden VH, Wierenga-Wolf AF, Adriaansen-Soet-ing PW, Overbeek SE, Möller GM, Hoogsteden HC, and Versnel MA: Expression of aminopeptidase N and dipepti-dyl peptidase IV in the healthy and asthmatic bronchus. Clin Exp Allergy. 1998;28:110-120. (Pubitemid 28053934)
20. Ersahin C, Szpaderska AM, Orawski AT, and Simmons WH: Aminopeptidase P isozyme expression in human tissues and peripheral blood mononuclear cell fractions. Arch Biochem Biophys. 2005;435:303-310. (Pubitemid 40222469)
21. Venema RC, Ju H, Zou R, Venema VJ, and Ryan JW. Cloning and tissue distribution of membrane-bound aminopeptidase P. Biochem Biophys Acta. 1997;1354:45-48. (Pubitemid 27479892)
22. Wetmore LA, Gerard C, and Drazen JM: Human lung ex-presses unique gamma-glutamyl transpeptidase transcripts. Proc Natl Acad Sci USA. 1993;90:7461-7465. (Pubitemid 23249969)
23. Hanigan MH, Frierson HF Jr, Swanson PE, and De Young BR: Altered expression of gamma-glutamyl transpeptidase in human tumors. Hum Pathol. 1999;30:300-305. (Pubitemid 29125150)
24. Rahman I, Bel A, Mulier B, Donaldson K, and MacNee W: Differential regulation of glutathione by oxidants and dexamethasone in alveolar epithelial cells. Am J Physiol. 1998;275(1 Pt 1):L80-L86.
25. Zaman K, Hanigan MH, Smith A, Vaughan J, Macdonald T, Jones DR, Hunt JF, and Gaston B: Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in air-way epithelial cells. Am J Respir Mol Biol. 2006;34:387-393.
26. Van der Velden VH, Naber BA, Van Hal PT, Overbeek SE, Hoogsteden HC, and Versnel MA: Peptidases in asthmatic airways. Adv Exp Med Biol. 2000;477:413-430.
27. Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Trotot P, Barbat A, and Trugnan G: Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J Biol Chem. 1992;267:4824-4833.
28. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, and Turner AJ: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-intensive carboxypeptidase. J Biol Chem. 2000;275:33238-33243.
29. Wang R, Zagariya A, Ibarra-Sunga O, Gidea C, Ang E, Deshmukh S, Chaudhary G, Baraboutis J, Filippatos G, and Uhal BD: Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol. 1999;276(5 Pt 1):L885-L889. (Pubitemid 29249642)
30. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robinson K, Jeya-seelan R, Breitbart RE, and Acton S: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000; 87:E1-E9.
31. Harmer D, Gilbert M, Borman R, and Clark KL: Quantitative expression profiling of ACE2, a novel homologue of angio-tensin converting enzyme. FEBS Lett. 2002;532:107-110. (Pubitemid 35375876)
32. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ, and van Goor H: Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631-637. (Pubitemid 38714099)
33. Tseng CT, Tseng J, Perrone L, Worthy M, Popov V, and Peters CJ: Apical entry and release of severe acute respira-tory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J Virol. 2005;79:9470-9479. (Pubitemid 41022291)
34. Lottaz D, Maurer CA, Hahn D, Büchler MW, and Sterchi EE: Nonpolarized secretion of human meprin alpha in colorectal cancer generates an increased proteo-lytic potential in the stroma. Cancer Res. 1999;59:1127-1133. (Pubitemid 29135976)
35. Cottrell GS, Amadesi S, Grady EF, and Bunnett NW: Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J Biol Chem. 2004;279:13532-13539. (Pubitemid 38468878)
36. Sporty JL, Horálková L, and Ehrhardt C: In vitro cell culture models for the assessment of pulmonary drug disposition. Expert Opin Drug Metab Toxicol. 2008;4:333-345. (Pubitemid 351728510)
37. Forbes B, and Ehrhardt C: Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Bio-pharm. 2005;60:193-205. (Pubitemid 40804561)
38. Woodley JF: Enzymatic barriers for GI peptide and pro-tein delivery. Crit Rev Ther Drug Carrier Syst. 1994;11:61-95.
39. Fogh J, and Trempe G: In J Fogh (ed). Human Tumor Cells In Vitro. Plenum Press, New York; pp. 115-159, 1975.
40. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, and Gruenert DC: CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1994;10:38-47.
41. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, and Parks WP: In vitro cultivation of human tu-mors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51:1417-1423.
42. http://snpper.chip.org/.
43. http://frodo.wi.mit.edu/.
44. http://www.ncbi.nlm.nih.gov/blast/Blast.cgi?PAGE=Nucleotides&PROGRAM= blastn&MEGABLAST=on&BLAST-PROGRAMS=megaBlast&PAGE-TYPE= BlastSearch&SHOW-DEFAULTS=on
45. Turner AJ, and Cottrell GS: Aminopeptidase P1. In: AJ Barrett, ND Rawlings, and JF Woessner JF (eds). Handbook of Proteolytic Enzymes, 2nd ed. Elsevier, London; pp. 931-933, 2004.
46. Inagaki M, Sakakura Y, Itoh H, Ukai K, and Miyoshi Y: Macromolecular permeability of the tight junction of the human nasal mucosa. Rhinology. 1985;23: 213-221. (Pubitemid 15239453)
47. Goldberg M, and Gomez-Orellana I: Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov. 2003;2: 289-295. (Pubitemid 37361687)
48. Patton JS, and Platz RM: Routes of delivery: Case studies\pulmonary delivery of peptides and proteins for systemic action. Adv Drug Deliv Rev. 1992;8:179-196.
49. Reid PT, Marsden ME, Cunningham GA, Haslett C, and Sallenave JM: Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific in-hibitor) in type II alveolar epithelial cells. FEBS Lett. 1999; 457:33-37 (Pubitemid 29387404)
50. Sadler JE: Enteropeptidase. In: AJ Barrett, ND Rawlings, and JF Woessner (eds). Handbook of Proteolytic Enzymes, 2nd ed. Elsevier, London; pp. 1513-1517, 2004.
51. Funkhouser JD, Cheshire LB, Ferrara TB, and Peterson RD: Monoclonal antibody identification of a type II alveolar ep-ithelial cell antigen and expression of the antigen during lung development. Dev Biol. 1987;119:190-198. (Pubitemid 17006265)
52. Gillis LD, Pendley DS, and Funkhouser JD: The major APN transcript of the alveolar type II epithelial cell originates from a unique upstream promoter region. Biochim Biophys Acta. 1998;1399:126-140. (Pubitemid 28410458)
53. Hiratake J, Suzuki H, and Kumagai H: y-Glutamyl trans-peptidase and its precursor. In: AJ Barrett, ND Rawlings, and JF Woessner (eds). Handbook ofProteolytic Enzymes, 2nd ed. Elsevier, London; pp. 2090-2094, 2004.
54. Dinsdale D, Green JA, Manson MM, and Lee MJ: The ul-trastructural immunolocalization of gamma-glutamyl-transpeptidase in rat lung: correlation with the histochemical demonstration of enzyme activity. Histochem J. 1992;24:144-152.
55. Ingbar DH, Hepler K, Dowin R, Jacobsen E, Dunitz JM, Nici L, and Jamieson JD: y-Glutamyl transpeptidase is a polarized alveolar epithelial membrane protein. Am J Physiol. 1995; 269(2 Pt 1):L261-L271.
56. Chen X, Orfanos SE, Ryan JW, Chung AY, Hess DC, and Catravas JD: Species variation in pulmonary endothelial aminopeptidase P activity. J Pharmacol Exp Ther. 1991;259:1301-1307
57. Skidgel RA, Davis RM, and Tan F: Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem. 1989;164:2236-2241. (Pubitemid 19057698)
58. Skeggs LT Jr, Kahn JR, and Shumway NP: The preparation and function of the hypertension-converting enzyme. J Exp Med. 1956;103:295-299.
59. Corvol P, Eyries M, and Soubrier F. Peptidyl-dipeptidase A/angiotensin I-converting enzyme. In: Barrett AJ, Rawlings ND, and Woessner JF (eds). Handbook ofProteolytic Enzymes, 2nd ed. Elsevier, London; pp. 332-346, 2004.
60. Turner AJ, and Hooper NM: Angiotensin-converting en-zyme 2. In: AJ Barrett, ND Rawlings, and JF Woessner (eds). Handbook of Proteolytic Enzymes, 2nd ed. Elsevier, London; pp. 349-352, 2004.
61. Kuba K, Imai Y, and Penninger JM: Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006;6: 271-276. (Pubitemid 43670913)
62. Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, and Uhal BD: Angiotensin converting enzyme-2 is protec-tive but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2008;295: L178-L185.
63. Chu TG, and Orlowski M: Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive paptides. Endocrinoloy. 1985;116:1418-1425. (Pubitemid 15078158)
64. Ray K, Hines CS, Coll-Rodriguez J, and Rodgers DW: Crystal structure of human thimet oligopeptidase provides insight into substrate recognition, regulation, and localization. J Biol Chem. 2004;279:20480-20489. (Pubitemid 38623495)
65. Choi HS, Lesser M, Cardozo C, and Orlowski M: Im-munohistochemical localization of endopeptidase 24.15 in rat trachea, lung tissue, and alveolar macrophages. Am J Respir Cell Mol Biol. 1990;3:619-624.
66. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, and Edgar R NCBI GEO: mining tens of millions of expression profiles\database and tools update. Nucleic Acids Res. 2007;35:D760-D765. (Pubitemid 46056306)